Medical Oncologist
Board-certified in hematology and oncology, Aditya Shreenivas, M.D., M.S., takes an individualized approach to treating cancer with leading-edge options, with a particular focus on gastrointestinal cancers and head and neck cancers. As a researcher, he focuses on studying innovative therapeutics and pioneering new approaches to precision medicine.
Dr. Shreenivas was inspired to become a doctor by his grandfather – a physician who founded India’s Indira Gandhi Institute of Cardiology – and his mother, a renowned obstetrician and gynecologist. He earned his medical degree at JSS Medical School in Mysuru, India, then completed a residency in internal medicine at Bronx-Lebanon Medical Center and a fellowship in hematology-oncology at Icahn School of Medicine at Mount Sinai, where he also earned a master’s degree in clinical research.
Dr. Shreenivas will also be affiliated with City of Hope's experimental therapeutics and early drug development program. He believes in the concept of vertical research, and the overall thrust of his research work has been focused on creating a small but significant impacts in the field of oncology. Dr. Shreenivas remains committed to a career focused on symptom management, experimental therapeutics, and precision medicine. He has co-authored several peer-reviewed articles, which have been published in journals like CA: A Cancer Journal for Clinicians and JCO-Precision Oncology, European Journal of Cancers and Blood, among others.
Before joining City of Hope, Dr. Shreenivas was an assistant professor of hematology-oncology at the Medical College of Wisconsin in Milwaukee, where he specialized in head and neck, gastrointestinal and rare cancers. Actively involved in clinical and translational research, he has grant funding from NRG Oncology and served as principal investigator of multiple industry-sponsored and investigator-initiated clinical trials.